Design, synthesis, and docking studies of novel telmisartan–glitazone hybrid analogs for the treatment of metabolic syndrome-Reference-Cited by-同舟云学术

Design, synthesis, and docking studies of novel telmisartan–glitazone hybrid analogs for the treatment of metabolic syndrome

Published:2009-01-27 Issue:7 Volume:18 Page:589-610
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Chittiboyina Amar G.,Mizuno Cassia S.,Desai Prashant V.,Patny Akshay,Kurtz Theodore W.,Pershadsingh Harrihar A.,Speth Robert C.,Karamyan Vardan,Avery Mitchell A.

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/s00044-008-9152-x.pdf

Reference18 articles.

1. Balmforth AJ, Lee AJ, Warburton P, Donnelly D, Ball SG (1997) The conformational change responsible for AT1 receptor activation is dependent upon two Juxtaposed asparagine residues on transmembrane helixes III and VII. J Biol Chem 272:4245–4251. doi: 10.1074/jbc.272.7.4245

2. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43:993–1002. doi: 10.1161/01.HYP.0000123072.34629.57

3. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438. doi: 10.1161/01.CIR.0000111245.75752.C6

4. Harrold M (2002) Foye’s principles of medicinal chemistry, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 533–561

5. Hoe K-L, Saavedra JM (2002) Site-directed mutagenesis of the gerbil and human angiotensin II AT1 receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. Mol Pharmacol 61:1404–1415. doi: 10.1124/mol.61.6.1404

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1H)-Quinolones with Single Dose Cures;Journal of Medicinal Chemistry;2021-05-12

2. Recent Advances in Therapeutic Applications of Bisbenzimidazoles;Medicinal Chemistry;2020-05-20

3. Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome;European Journal of Medicinal Chemistry;2019-07

4. Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones;European Journal of Medicinal Chemistry;2019-04

5. Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor;European Journal of Medicinal Chemistry;2018-10